Néoplasie

Fr | De

Feedback | Impressum | Sitemap

Aucun choix d'articles!

Panier

Vous êtes ici: Recherche de documentation spécialisée » Œsophage » Néoplasie

26. Octobre 2026

Dépistage / diagnostic

Recherche de documentation spécialisée

Troubles de la motilité

Écriture:

Page 1 de 1998


	Articles 1 - 20 / 39944

	Neoadjuvant immunotherapy for locally advanced resectable gastric and gastroesophageal junction adenocarcinoma: a systematic review and meta-analysis. BMC Surg Osman IM, Peng S, Liu H, Zhen W, Ma S, Wang Q. PMID: 42928166 [PubMed - indexed for MEDLINE]
	Establishment of an enteral nutrition pathway for malignant esophageal obstruction using combined esophageal stenting and gastrostomy. BMC Gastroenterol Huang W, Lian T, Chen H, Lin B, Qian O, Lu D, Zhuang Z. PMID: 42928134 [PubMed - indexed for MEDLINE]
	Systematic Review and Meta-Analysis of Patients with Esophageal Cancer and Intramural Metastasis. Ann Thorac Cardiovasc Surg Sato S, Shimada H, Takeda Y, Endo I, Yoshikawa T. PMID: 42927908 [PubMed - indexed for MEDLINE]
	Alcohol Non-Abstinence and Hypertension as Independent Risk Factors for Esophageal Cancer Recurrence After Endoscopic Submucosal Dissection: A Multicenter Cohort Study. Kurume Med J Emori K, Fukunaga S, Mukasa M, Nakane T, Cho T, Minami S, Tanaka H, Ohzono D, Yoshio T, Watanabe Y, Nakano D, Tsutsumi T, Araki T, Morita T, Torimura T, Nouno R, Takedatsu H, Kawaguchi T. PMID: 42927902 [PubMed - as supplied by publisher]
	ctDNA clearance and outcomes for resectable lung cancer from NeoCOAST-2. Nature McGrath L, Kar G, Bonanno L, Guisier F, Insa A, Liberman M, Bylicki O, Livi L, Egenod T, Corre R, Kim DW, Garcia Campelo MR, Provencio Pulla M, Shim BY, Metro G, Bennouna J, Bielska AA, Yohannes AR, Shaju J, He Y, Dowson A, Grenga I, Spicer J, Forde PM, Cascone T. PMID: 42927884 [PubMed - as supplied by publisher]
	Prognostic associations between patient-reported outcomes and progression-free and overall survival in advanced gastric or gastroesophageal junction adenocarcinoma with PD-L1 TAP scoreâ€‰â‰¥â€‰5%: results from the RATIONALE-305 trial. Qual Life Res Moehler M, Correa MC, Oh DY, Xu RH, Kato K, Barzi A, Barnes FB, Xu Y, Sheng T, Barnes G, Victor T. PMID: 42927580 [PubMed - indexed for MEDLINE]
	Locoregional and distant recurrence after neoadjuvant chemoimmunotherapy versus chemoradiotherapy in esophageal squamous cell carcinoma: a focused meta-analysis. BMC Cancer Ruan Y, Cao W, Long C, Li C, Han J. PMID: 42926222 [PubMed - indexed for MEDLINE]
	A revised postneoadjuvant pathologic stage grouping for esophageal squamous cell carcinoma: A dual-center study. Eur J Surg Oncol Geng Z, Li X, Zhou J, Zhang H, Xiao X, Li F, Fang P, Luan S, Zhu W, Peng Y, Zhang L, Wang Z, Qi Y, Yuan Y. PMID: 42925639 [PubMed - as supplied by publisher]
	From endoscopic diagnosis to curative treatment: superficial pharyngeal cancer. VideoGIE Nobre R, Fortes Y, Andrade de Paulo G, da Costa Martins B, Lenz L, Vaz Safatle-Ribeiro A, Maluf-Filho F. PMID: 42923848 [PubMed]
	The Predictive Value of the Systemic Immune-Inflammation Index Combined With Clinical Stage for the Prognosis of Oesophageal Cancer Patients Treated With Radiotherapy: A Retrospective Cohort Study and Meta-Analysis. Cancer Med Ou Y, Liu Q, Yang D, Chen L, Yu J. PMID: 42922016 [PubMed - indexed for MEDLINE]
	Label-Free Microfiber Biosensor Reveals PD-L1 Autoantibodies as Predictive Biomarkers in Esophageal Squamous Cell Carcinoma. ACS Sens Li Z, Xie R, Wang X, Xie Y, Liu S, Xv Z, Luo J, Chen Y, Lun J, Li H, Zhang J, Ma H, Pu S, Rao L, Sang X, Farrell G, Yuan J, Chen S, Wu Q. PMID: 42921877 [PubMed - indexed for MEDLINE]
	Towards reliable morphological subtyping and cancer detection on Barrett's esophagus pathology through ensembling foundation models. NPJ Digit Med Kazemi A, Saueressig C, Liu J, Li H, Shakhtour J, Grosser B, Stögbauer F, Horstmann J, Navab N, Eslami S, Quante M, Slotta-Huspenina J, Schüffler PJ. PMID: 42919834 [PubMed]
	Active surveillance versus standard surgery after neoadjuvant chemoradiotherapy for oesophageal cancer: long-term results of a cluster-randomised controlled trial (SANO). Ann Oncol Panday SSGG, van der Wilk BJ, Lagarde SM, Eyck BM, Rosman C, Noordman BJ, Valkema MJ, Bisseling TM, Coene PPLO, van Det MJ, Dekker JWT, van Dieren JM, Doukas M, van Esser S, Fiets WE, Hartgrink HH, Heisterkamp J, Holster IL, Klarenbeek B, Kouw E, Kouwenhoven EA, Luyer MD, Mostert B, Nieuwenhuijzen GAP, Oostenbrug LE, Pierie JP, van Sandick JW, Sosef MN, Spaander MCW, Valkema R, van der Zaag ES, Steyerberg EW, van Klaveren D, Wijnhoven BPL, van Lanschot JJB, SANO Study Group. PMID: 42918421 [PubMed - as supplied by publisher]
	Circulating MicroRNAs Reflect Systemic Inflammation and Metabolic Dysfunction in Oesophageal Squamous Cell Carcinoma-Associated Cachexia. J Cachexia Sarcopenia Muscle Li Y, Chen R, Lv X, Wei S, Xu Y, Ding S. PMID: 42910566 [PubMed - indexed for MEDLINE]
	Lymph Node Regression Improves Prognostic Stratification in Esophageal Squamous Cell Carcinoma Receiving Neoadjuvant Chemoimmunotherapy: A Multicenter Retrospective Cohort Study. MedComm (2020) Zheng J, Shen W, Cao J, Gao L, Zan L, Zhang T, Gong L, Duan X, Wang X, Wu Y, Tang P, Jiang H, Pang Q, Zhao G, Zhang W, Yan C. PMID: 42910074 [PubMed]
	Esophageal Carcinoma Incidence and Survival Analysis: A Population-Based Cancer Registry Study in Central India. Cureus Ghongade PV, Patil BU, Gupta A, Maliye S, Gangane N. PMID: 42909884 [PubMed]
	Visualizing the distribution of durvalumab targeting PD-L1 using quantitative fluorescence imaging in patients with esophageal cancer. Theranostics van der Waaij AM, van Ginkel YJ, Volkmer P, Kats-Ugurlu G, Huizinga HK, Hone Lopez S, de Haan JJ, Bijlsma R, van der Waaij LA, Muijs CT, Niezink AGH, van Etten B, Westerhof J, di Pietro M, Robinson DJ, Lub-de Hooge MN, Nagengast WB. PMID: 42909237 [PubMed - indexed for MEDLINE]
	Survival outcomes and safety of adding high-dose-rate intraluminal brachytherapy (HDR-ILBT) utilizing the novel balloon applicator (BRAXX) following concurrent chemoradiotherapy (CCRT) for non-surgical esophageal cancer: a prospective pilot and real-world comparative study. Am J Cancer Res Chen SH, Kao WH, Tsan DL, Yap WK, Hung TM, Chen MF, Pai PC, Lin AC, Lu WH, Tseng CK. PMID: 42908863 [PubMed]
	Efficacy of tislelizumab combined with nab-paclitaxel and nedaplatin in advanced esophageal squamous cell carcinoma and its impact on serum tumor markers. Am J Cancer Res Huang R, Shen G, Zhang W, Lin Y, Huang Z, Dai Y, Lin Y, Zhang Y. PMID: 42908730 [PubMed]
	Underweight Versus Obesity and Gastrointestinal Cancer Mortality in Type 2 Diabetes: A Nationwide Cohort Study. J Cachexia Sarcopenia Muscle Park JH, Han K, Choe HJ, Park SE, Lee WY, Moon SJ, Rhee EJ. PMID: 42908126 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 39944

Page 1 de 1998



		Intervalle de temps demandé

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy \| Publicité